You just read:

Orexigen Therapeutics Announces Commercialization and Distributorship Arrangement with Navamedic ASA for Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in Five Nordic Countries

News provided by

Orexigen Therapeutics, Inc.

May 02, 2017, 03:00 ET